20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding Metaraminol Bitartrate: CAS 33402-03-8 for Hypotensive Treatments

In the realm of critical medical treatments, maintaining stable hemodynamic parameters is often the key to patient survival and recovery. Metaraminol bitartrate, identified by its CAS number 33402-03-8, is a cornerstone pharmaceutical intermediate renowned for its efficacy in managing hypotension. Its powerful sympathomimetic and vasopressor actions make it an essential component in formulations aimed at supporting blood pressure in various critical scenarios.

The primary utility of Metaraminol bitartrate lies in its ability to counteract acute drops in blood pressure. This is particularly relevant in contexts such as spinal anesthesia, where the sympathetic nervous system can be significantly impaired, leading to hypotension. Furthermore, it serves as an adjunctive treatment for hypotension resulting from profound blood loss, adverse drug reactions, surgical complications, or the shock associated with severe trauma. As a leading Metaraminol bitartrate manufacturer in China, we pride ourselves on delivering a product that meets the highest purity standards, ensuring the safety and effectiveness of the final pharmaceutical products.

For pharmaceutical companies and formulators, securing a consistent supply of high-quality Metaraminol bitartrate is crucial for uninterrupted production. We understand the importance of a reliable supply chain and competitive Metaraminol bitartrate pricing. Our role as a Metaraminol bitartrate supplier extends to providing robust support, from initial inquiries to bulk orders. We aim to be your go-to source for this vital intermediate, offering the confidence that comes with working with an experienced and dedicated manufacturer.

If your organization is seeking to buy Metaraminol bitartrate, we invite you to engage with our team. We are committed to providing detailed product information, competitive quotes, and a seamless procurement experience. Partner with us to ensure your formulations have access to the quality Metaraminol bitartrate they require for impactful therapeutic outcomes.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Metaraminol Bitartrate: A Key Intermediate for Vasopressor Drug Development

Next: Procuring Metaraminol Bitartrate: Quality and Supply Chain from China

All Rights Reserved